Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

[Management of non-small cell lung cancer patients harboring activating mutations and CNS progression].

Rouviere D, Veillon R, Chaltiel L, Simonneau Y, Filleron T, Milia J, Guibert N, Melloni B, Raherison C, Didier A, Mazieres J.

Rev Mal Respir. 2019 May;36(5):583-590. doi: 10.1016/j.rmr.2019.04.003. Epub 2019 Jun 13. French.

PMID:
31202602
2.

Integration of interventional bronchoscopy in the management of lung cancer.

Guibert N, Mazieres J, Marquette CH, Rouviere D, Didier A, Hermant C.

Eur Respir Rev. 2015 Sep;24(137):378-91. doi: 10.1183/16000617.00010014. Review.

3.

[New targets and new drugs in thoracic oncology].

Rouviere D, Bousquet E, Pons E, Milia JD, Guibert N, Mazieres J.

Rev Mal Respir. 2015 Oct;32(8):867-76. doi: 10.1016/j.rmr.2015.02.091. Epub 2015 Jun 12. Review. French.

PMID:
26076869
4.

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.

Mazières J, Zalcman G, Crinò L, Biondani P, Barlesi F, Filleron T, Dingemans AM, Léna H, Monnet I, Rothschild SI, Cappuzzo F, Besse B, Thiberville L, Rouvière D, Dziadziuszko R, Smit EF, Wolf J, Spirig C, Pecuchet N, Leenders F, Heuckmann JM, Diebold J, Milia JD, Thomas RK, Gautschi O.

J Clin Oncol. 2015 Mar 20;33(9):992-9. doi: 10.1200/JCO.2014.58.3302. Epub 2015 Feb 9.

PMID:
25667280
5.

Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting.

Bylicki O, Rouvière D, Cassier P, Chalabreysse L, Levard A, Maury JM, Margery J, Blay JY, Mazières J, Girard N.

J Thorac Oncol. 2015 Feb;10(2):309-15. doi: 10.1097/JTO.0000000000000401.

Supplemental Content

Loading ...
Support Center